• mainvisual01mainvisual01World-Leading CRO Drug Efficacy Assessment  with Disease Animal ModelsWorld-Leading CRO Drug Efficacy Assessment  with Disease Animal Models
  • mainvisual02mainvisual02Tried and True Drug Efficacy Assessment  with Disease Animal ModelsTried and True Drug Efficacy Assessment  with Disease Animal Models
  • mainvisual03mainvisual03Further Your Research Drug Efficacy Assessment  with Disease Animal ModelsFurther Your Research Drug Efficacy Assessment  with Disease Animal Models
Image(Products & Services) is for illustration purposes.Image(Products & Services) is for illustration purposes.

Products & Services

  • NASH-HCCNASH-HCC
  • Pulmonary fibrosisPulmonary fibrosis
  • Other disease modelOther disease model
  • HistologyHistology
  • BiospecimensBiospecimens
Image(aboutus) is for illustration purposes.Image(aboutus) is for illustration purposes.

About us

SMC Laboratories has conducted nonclinical pharmacology study service over 10 years and has over 500 clients globally. It was our proprietary STAM™ mice that made us a leading CRO in NASH-HCC research field. In addition to our strong expertise in liver research, SMC Laboratories has accumulated know-how in various experimental conditions associated with metabolic disorders, diabetes, inflammation, fibrosis and cancer, and expanded our service to various disease settings.

Image(recruit) is for illustration purposes.Image(recruit) is for illustration purposes.

Recruit

SMC Laboratories, Inc. is a non-clinical CRO based in Tokyo, Japan, who is specialized in Fibrosis and Inflammation researches.
SMC is looking for an intelligent, proactive, responsible and trainable professional to join our team. We rely on the diversity of our workforce to drive our growth and success.
Our competitive salaries and benefits, as well as unlimited opportunities for professional growth and development, make SMC a great place to work.